Keith Kendall

Keith Kendall

Geen lopende functies

Vermogen: 3 M $ op 31-03-2024

66 jaar
Health Technology
Consumer Services
Electronic Technology

Profiel

Keith J.
Kendall
served as President, Chief Executive Officer & Director at Aquestive Therapeutics, Inc. from 2014 to 2022.
Prior to that, he was Vice President & Managing Director at Hewlett-Packard Financial Services Co. from 1999 to 2006.
He also served as Non-Executive Director at Biodexa Pharmaceuticals Plc from 2010 to 2014.
Before his time at Hewlett-Packard, he was President at CIT Communications Finance Corp.
and NCR Credit Corp.
from 1985 to 1998.
Kendall holds an MBA from Pace University and an undergraduate degree from St. John's University.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
15-03-2023 637 149 ( 0.71% ) 3 M $ 31-03-2024

Eerdere bekende functies van Keith Kendall

BedrijvenFunctieEinde
FEMASYS INC. Director/Board Member 08-11-2023
AQUESTIVE THERAPEUTICS, INC. Chief Executive Officer 17-05-2022
BIODEXA PHARMACEUTICALS PLC Director/Board Member 01-12-2014
Corporate Officer/Principal 01-06-2006
President -
Ervaring van Keith Kendall in detail bekijken

Opleiding van Keith Kendall

Pace University Masters Business Admin
St. John's University Undergraduate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Keith Kendall in detail bekijken

Connecties

40

Eerstegraads connecties

8

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven3
FEMASYS INC.

Electronic Technology

AQUESTIVE THERAPEUTICS, INC.

Health Technology

BIODEXA PHARMACEUTICALS PLC

Health Technology

Bedrijven in privébezit3

Commercial Services

Finance

NCR Credit Corp.

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Keith Kendall